Clarity Medical Group (1406) Announces Appointments of New Directors, Changes Authorised Representative, and Re-Complies with Listing Requirements

Clarity Medical Group Holding Limited (Stock Code: 1406) has appointed two new directors with effect from 11 November 2025. According to the announcement, Dr. Chen Poujian has been named as an Independent Non-Executive Director and will also serve as a member of the audit committee. Dr. Chen’s term extends for three years, entitling him to an annual director’s remuneration of HK$300,000. He brings over 35 years of experience in insurance and investment, holding a PhD in Economics and serving previously as chairman of Ruihua Health Assurance Corporation.

On the same date, the board appointed Professor Wang Qinmei as a Non-Executive Director for a three-year term with an HK$300,000 annual remuneration. A professor and chief physician at Wenzhou Medical University, Professor Wang has contributed more than four decades to the field of ophthalmology and optometry.

The company further announced that, as of 11 November 2025, Mr. Jiang Bo has replaced Mr. Hui Yung Chris as the authorised representative under the Listing Rules. Following the new appointments, Clarity Medical Group Holding Limited has re-complied with the audit committee requirements set by Rule 3.21 of the Listing Rules.